References
- Cartwright R A, Watkins G. Epidemiology of Hodgkin's disease: a review. Hematol Oncol 2004; 22: 11–26
- Hayes J D, Flanagan J U, Jowsey I R. Glutathione transferases. Annu Rev Pharmacol Toxicol 2005; 45: 51–88
- Zimniak P, Nanduri B, Pikula S, Bandorowicz-Pikuła J, Singhal S S, Srivastava S K, et al. Naturally occuring human glutathione S-transferase GSTP1 isoforms with isoleucine and valine in position 104 differ in enzimatic properties. Eur J Biochem 1994; 224: 893–899
- Kellen E, Hemelt M, Broberg K, Golka K, Kristensen V N, Hung R J, et al. Pooled analysis and meta-analysis of the glutathione S-transferase P1 Ile 105Val polymorphism and bladder cancer: a HuGE-GSEC review. Am J Epidemiol 2007; 65: 1221–1230
- Sundberg K, Johansson A S, Stenberg G, Widersten M, Seidel A, Mannervik B, et al. Differences in the catalytic efficiencies of allelic variants of glutathione transferase PI-1 towards carcinogenic diol epoxides of polycyclic aromatic hydrocarbons. Carcinogenesis 1998; 19: 433–436
- Holley S L, Fryer A A, Haycock J W, Grubb S E, Strange R C, Hoban P R. Differential effects of glutathione S-transferase pi (GSTP1) haplotypes on cell proliferation and apoptosis. Carcinogenesis 2007; 28: 2268–2273
- Lemos M C, Cabrita F J, Silva H A, Vivan M, Plácido F, Regateiro F J. Genetic polymorphism of CYP2D6, GSTM1 and NAT2 and susceptibility to haematological neoplasias. Carcinogenesis 1999; 20: 1225–1229
- Sarmanová J, Benesová K, Gut I, Nedelcheva-Kristensen V, Tynková L, Soucek P. Genetic polymorphisms of biotransformation enzymes in patients with Hodgkin's and non-Hodgkin's lymphomas. Hum Mol Genet 2001; 10: 1265–1273
- Soucek P, Sarmanová J, Kristensen V N, Apltauerová M, Gut I. Genetic polymorphisms of biotransformation enzymes in patients with Hodgkin's and non-Hodgkin's lymphomas. Int Arch Occup Environ Health 2002; 75: S86–S92
- Hohaus S, Massini G, D'Alo’ F, Guidi F, Putzulu R, Scardocci A, et al. Association between glutathione S-transferase genotypes and Hodgkin's lymphoma risk and prognosis. Clin Cancer Res 2003; 9: 3435–3440
- Ribrag V, Koscielny S, Casasnovas O, Cazeneuve C, Brice P, Morschhauser F, et al. Pharmacogenetic study in Hodgkin's lymphomas reveals the impact of UGT1A1 polymorphisms on patient's prognosis. Blood 2009; 113: 3307–3313
- Hohaus S, Di Ruscio A, Di Febo A, Massini G, D'Alo’ F, Guidi F, et al. Glutathione S-transferase P1 genotype and prognosis in Hodgkin's lymphoma. Clin Cancer Res 2005; 11: 2175–2179
- Duncan B B, Schmidt M I, Polansky C A. High mortality rates among Brazilian adult populations-an international comparison. Rev Assoc Med Bras 1992; 38: 138–144
- Ruiz M A, Augusto L GS, Vassallo J, Vigorito A C, Lorand-Metze I, Souza C A. Bone marrow morphology in patients with neutropenia due to chronic exposure to organic solvents. Pathol Res Pract 1994; 190: 151–154
- Augusto L GS, Vigorito A C, De Souza C A. Histological damage in bone marrow by exposure to benzene and follow-up of peripheral blood count of chronic intoxication. Rev Bras Saude Ocup 1993; 78: 85–92
- Arruda V R, Lima C SP, Grignoli C RE, Melo M B, Lorand-Metze I, Alberto F L, et al. Increased risk for acute myeloid leukaemia in individuals with glutathione S-transferase mu 1 (GSTM1) and tetha 1 (GSTT1) gene defects. Eur J Haematol 2001; 66: 383–388
- Watson M A, Stewart R K, Smith G B, Massey T E, Bell D A. Human glutathione S-transferase P1 polymorphisms: relationship to lung tissue enzyme activity and population frequency distribution. Carcinogenesis 1998; 19: 275–280